Optimizing a therapeutic humanized follicle‐stimulating hormone–blocking antibody formulation by protein thermal shift assay
- 11 January 2023
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1521 (1) , 67-78
Abstract
Biopharmaceutical products are formulated using several Food and Drug Administration (FDA) approved excipients within the inactive ingredient limit to maintain their storage stability and shelf life. Here, we have screened and optimized different sets of excipient combinations to yield a thermally stable formulation for the humanized follicle‐stimulating hormone (FSH)–blocking antibody, MS‐Hu6. We used a protein thermal shift assay in which rising temperatures resulted in the maximal unfolding of the protein at the melting temperature (Tm). To determine the buffer and pH for a stable solution, four different buffers with a pH range from 3 to 8 were screened. This resulted in maximal Tms at pH 5.62 for Fab in phosphate buffer and at pH 6.85 for Fc in histidine buffer. Upon testing a range of salt concentrations, MS‐Hu6 was found to be more stable at lower concentrations, likely due to reduced hydrophobic effects. Molecular dynamics simulations revealed a higher root‐mean‐square deviation with 1 mM than with 100 mM salt, indicating enhanced stability, as noted experimentally. Among the stabilizers tested, Tween 20 was found to yield the highest Tm and reversed the salt effect. Among several polyols/sugars, trehalose and sucrose were found to produce higher thermal stabilities. Finally, binding of recombinant human FSH to MS‐Hu6 in a final formulation (20 mM phosphate buffer, 1 mM NaCl, 0.001% w/v Tween 20, and 260 mM trehalose) resulted in a thermal shift (increase in Tm) for the Fab, but expectedly not in the Fc domain. Given that we used a low dose of MS‐Hu6 (1 μM), the next challenge would be to determine whether 100‐fold higher, industry‐standard concentrations are equally stable.Keywords
Funding Information
- National Institutes of Health (R01 AG074092, P20 GM121301, R01 AG071870, R01 DK113627, U01 AG073148, U19 AG060917)
This publication has 37 references indexed in Scilit:
- Effect of Polysorbate 80 Concentration on Thermal and Photostability of a Monoclonal AntibodyAAPS PharmSciTech, 2012
- Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesisProceedings of the National Academy of Sciences, 2012
- On the role of salt type and concentration on the stability behavior of a monoclonal antibody solutionBiophysical Chemistry, 2012
- Immunogenicity of protein aggregates—Concerns and realitiesInternational Journal of Pharmaceutics, 2012
- Interactions of formulation excipients with proteins in solution and in the dried stateAdvanced Drug Delivery Reviews, 2011
- ACEMD: Accelerating Biomolecular Dynamics in the Microsecond Time ScaleJournal of Chemical Theory and Computation, 2009
- Polysorbates 20 and 80 Used in the Formulation of Protein Biotherapeutics: Structure and Degradation PathwaysJournal of Pharmaceutical Sciences, 2008
- Antibody Structure, Instability, and FormulationJournal of Pharmaceutical Sciences, 2007
- Effects of Temperature and Salt Concentration on the Structural Stability of Human Lymphotactin: Insights from Molecular SimulationsJournal of the American Chemical Society, 2006
- The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain ProteinBiophysical Journal, 2000